CAS: 147030-48-6; 2-(2,6-Diiodo-4-((2-Methylbenzofuran-3-yl)Methyl)Phenoxy)Acetic Acid

该化合物是一种结构复杂的有机化合物,其结构复杂,含有二碘酚核心,通过甲基苯基桥与2-甲基苯甲酸酯混合物相连,并带有乙酸功能组.该化合物对合成化学和药用化学具有兴趣,因为它作为发展生物活性分子的中间体具有潜力.碘原子的存在增强了其在放射性标签应用中的效用,而苯甲酸盐组则有助于其稳定性和分子相互作用的结合.其定义明确的结构使它适合精确的化学修改,能够使药物研究和材料科学有针对性地应用.

结构式图片

上下游产品

2,6-二碘-4-[(2-甲基-1-苯并呋喃-3-基)甲基]苯酚 2-Methyl-3-(3,5-Diiodo-4-Hydroxybenzyl)Benzofuran 401917-61-1
2-[4-(2-丁基-1-苯并呋喃-3-羰基)-2,6-二碘苯氧基]乙酸 2-N-Butyl-3-(3,5-Diiodo-4-Carboxymethoxy-Benzoyl)Benzofuran 147030-47-5
(4-羟基-3,5-二碘苯基)(2-甲基-1-苯并呋喃-3-基)甲酮 2-Methyl-3-(3,5-Diiodo-4-Hydroxybenzoyl)Benzofuran 10402-56-9
(4-甲氧基苯基)(2-甲基-1-苯并呋喃-3-基)甲酮 2-Methyl-3-(4'-Methoxybenzoyl)Benzofuran 94541-06-7

合成工艺路线路线简述

    📜(4-甲氧基苯基)(2-甲基-1-苯并呋喃-3-基)甲酮置于吗啉,Sodium Hydroxide,Sodium Tetrahydroborate,Tetramethylammonium Dichloroiodate,吡啶盐酸盐,Potassium Carbonate,Zinc(II) Iodide体系中,用 甲醇,1,2-二氯乙烷,N,N-二甲基甲酰胺 用作溶剂,化学反应 7.75H,反应生成{2,6-二碘-4-[(2-甲基-1-苯并呋喃-3-基)甲基]苯氧基}乙酸
    参考文献:Synthesis And Preliminary Characterization Of A Novel Antiarrhythmic Compound (Kb130015) With An Improved Toxicity Profile Compared With Amiodarone
    标题:Synthesis And Preliminary Characterization Of A Novel Antiarrhythmic Compound (Kb130015) With An Improved Toxicity Profile Compared With Amiodarone
    摘要:Recent Developments In Antiarrhythmic Therapy Have Indicated That The Best Approach To Pharmacologically Controlling Supraventricular Arrhythmias And Life-Threatening Ventricular Tachyarrhythmias Is By Prolonging Cardiac Repolarization Rather Than By Blocking Conduction. In This Context,Amiodarone Has Emerged As The Most Potent Compound,But Its Universal Use Has Been Limited By Its Toxicity Profile. There Are Data To Suggest That An Important Component Of Amiodarones Antiarrhythmic Action Might Be Mediated Via Inhibition Of Thyroid Hormone Action In The Heart. Therefore,A New Series Of Carboxymethoxybenzoyl And Benzyl Derivatives Of Benzofuran Has Been Prepared And Evaluated As Thyroid Hormone Receptor Antagonists. Within This Series,2-Methyl-3-(3,5-Diiodo-4-Carboxymethoxybenzyl)Benzofuran Kb130015 (7) Was Found To Reveal The Most Promising In Vitro Data. It Inhibits The Binding Of I-125-T-3 To The Human Thyroid Hormone Receptors (Hthr) Alpha(1) And Beta(1). T-3-Antagonism Was Confirmed In Reporter Cell Assays Employing Chokl Cells (Chinese Hamster Ovary Cells) Stably Transfected With Hthralpha(1) Or Hthrbeta(1) And An Alkaline Phosphatase Reporter Gene Downstream A Thyroid Response Element. The Derived Ic50 Values Were 2.2 Mum For Hthralpha(1) And 4.1 Mum For Hthrbeta(1). Compound 7 Was Selected For Further Characterization Of Chronic Effects On Ventricular Papillary Muscle By Transmembrane Electrophysiology After Daily Intraperitoneal Injection Of The Ligand (40 Mg/kg Body Weight) In Guinea Pigs. Compound 7 Was Found To Prolong The Action Potential Duration At 90% (Apd(90)) Repolarization Time (219 +/-22 Ms,Control: 186 +/-9 Ms,P < 0.01) Without Exhibiting Any Reverse-Rate Dependency Of Action In A Manner Similar To That Of Amiodarone. In General,Preliminary Tolerance Experiments With 7 Demonstrated An Improved Safety Profile Compared To That Of Amiodarone. In Summary,7 Appears To Be Less Toxic Than Amiodarone While Maintaining Its Electrophysiologic Properties Consistent With Antiarrhythmic Activity. Its Potential Antiarrhythmic Actions Warrant Further Investigations.
    Doi:10.1021/jm001126+

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Gessner G, Macianskiene R, Starkus JG, Schönherr R, Heinemann SH. The amiodarone derivative KB130015 activates hERG1 potassium channels via a novel mechanism. Eur J Pharmacol. 2010 Apr 25;632(1-3):52-9. doi: 10.1016/j.ejphar.2010.01.010. Epub 2010 Jan 25.
    2: Gessner G, Heller R, Hoshi T, Heinemann SH. The amiodarone derivative 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015) opens large- conductance Ca2+-activated K+ channels and relaxes vascular smooth muscle. Eur J Pharmacol. 2007 Jan 26;555(2-3):185-93. doi: 10.1016/j.ejphar.2006.10.053. Epub 2006 Oct 28. 100(11):697-703. German. doi: 10.1007/s00063-005-1096-z. 316(1):162-8. doi: 10.1124/jpet.105.092221. Epub 2005 Sep 16. 13(4):415-26. doi: 10.1517/13543784.13.4.415. 287(2):L438-47. doi: 10.1152/ajplung.00434.2003. Epub 2004 Apr 9. 308(1):134-42. doi: 10.1124/jpet.103.057646. Epub 2003 Oct 20. 21(3):216-35. doi: 10.1111/j.1527-3466.2003.tb00117.x. 139(8):1469-79. doi: 10.1038/sj.bjp.0705379.
    10: Macianskiene R, Viappiani S, Sipido KR, Mubagwa K. Slowing of the inactivation of cardiac voltage-dependent sodium channels by the amiodarone derivative 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015). J Pharmacol Exp Ther. 2003 Jan;304(1):130-8. doi: 10.1124/jpet.102.042218. 45(3):623-30. doi: 10.1021/jm001126+.

    合成参考文献


    参考文献:10.1007/978-3-031-52197-3_5
    摘要:Gamper N, Huang D, Qi J, Dong L, Zhang H. Therapeutic Targeting of Potassium Channels. 2024. In: Ion Channels as Targets in Drug Discovery.
    参考文献:10.1021/jm050004k
    摘要:Hedfors A, Appelqvist T, Carlsson B, Bladh LG, Litten C, Agback P, Grynfarb M, Koehler KF, Malm J. Thyroid receptor ligands. 3. Design and synthesis of 3,5-dihalo-4-alkoxyphenylalkanoic acids as indirect antagonists of the thyroid hormone receptor. J Med Chem. 2005 May 05;48(9):3114–7. doi: 10.1021/jm050004k.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知